Hvidovre University Hospital
Hvidovre, 2650, Denmark
NCT Number: NCT03728959
Hypoparathyroidism (hypoPT) is characterized by low levels of PTH.
In this study we will test the effects of a liquid meal on the bone remodeling in participants with hypoparathyroidism. Furthermore, we will test the effects of the gut hormones GIP and GLP-2.
Looking for future studies?
Notify Me18 year–76 year
All sexes
Interventional
Not applicable
Hvidovre, 2650, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Liquid meal ingested over 1 minute.
Subcutaneous injected GIP
Subcutaneous injected GLP-2
Subcutaneous injected Placebo (saline)
Time frame: -10 to 240 minutes
Marker of bone resorption, measured in serum
Time frame: -10 to 240 minutes
Marker of bone formation, concentration measured in serum
Time frame: -10 to 240 minutes
PTH concentration measured in serum
Time frame: -10 to 240 minutes
Gut hormone, concentration measured in plasma
Time frame: -10 to 240 minutes
Gut hormone, concentration measured in plasma
Time frame: -10 to 240 minutes
Gut hormone, concentration measured in plasma
Time frame: -10 to 240 minutes
Glucose concentration measured in serum
Time frame: -10 to 240 minutes
Insulin concentration measured in serum
Time frame: -10 to 240 minutes
C-peptide concentration measured in serum
Time frame: -10 to 240 minutes
Blood pressure (systolic and diastolic) measured before blood sampling
Time frame: -10 to 240 minutes
Heart rate measured before blood sampling
University of Copenhagen
Other
Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism (KS-4-HypoPT).
Acronym: KS-4-HypoPT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01922440
Endocrine System Diseases, Hypoparathyroidism
Birmingham, Alabama, United States
View Trial DetailsNCT04701203
Endocrine System Diseases, Hypoparathyroidism
San Francisco, California, United States
View Trial DetailsNCT02924532
Endocrine System Diseases, Hypoparathyroidism
Nîmes, Gard, France
View Trial DetailsNCT04009291
Endocrine System Diseases, Hypoparathyroidism
Chicago, Illinois, United States
View Trial Details